SCHEMBL20313486

SCHEMBL20313486

C=C(CO)C(=O)Oc1cc(OC(=O)C(=C)CO)cc(C2CCC(CCCCC)CC2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.36
MAPT P10636 3/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
CCR2 P41597 1/20 0.33
PKM P14618 1/20 0.33
HTT P42858 1/20 0.32
NAAA Q02083 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
CNR1 P21554 1/20 0.31
CNR2 P34972 1/20 0.31
TP53 P04637 1/20 0.31
ITGB3 P05106 1/20 0.31
ITGA2B P08514 1/20 0.31
OPRM1 P35372 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19855157 0.93 CYP2C9 (0.32) CYP2C9MAPTALDH1A1LMNAMEN1
SCHEMBL20313621 0.93 CYP2C9 (0.32) CYP2C9MAPTALDH1A1LMNAMEN1
SCHEMBL19855166 0.92 CYP2C9 (0.32) CYP2C9MAPTALDH1A1LMNAMEN1
SCHEMBL20313629 0.92 CYP2C9 (0.32) CYP2C9MAPTALDH1A1LMNAMEN1
SCHEMBL19854576 0.90 CYP2C9 (0.31) CYP2C9MAPTMEN1KMT2A
SCHEMBL19855547 0.89 CYP2C9 (0.40) CYP2C9MAPTALDH1A1LMNAMEN1
SCHEMBL19854418 0.89 CYP2C9 (0.40) CYP2C9MAPTALDH1A1LMNAMEN1
SCHEMBL20313536 0.88 CYP2C9 (0.44) CYP2C9MAPTALDH1A1LMNAMEN1
SCHEMBL19721839 0.88 CYP2C9 (0.44) CYP2C9MAPTALDH1A1LMNAMEN1
SCHEMBL19722254 0.87 CYP2C9 (0.43) CYP2C9MAPTALDH1A1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214615-A1 LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT JNC CORPORATION (JP) 2021-07-15 US disclosed
EP-3351525-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT JNC Corporation (JP) 2018-07-25 EP disclosed
US-20180179443-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-06-28 US disclosed
US-20180179443-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180179443-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE C1S, CCND1, C5 CYP2C9 3375/4885MAPT 2030/4885ALDH1A1 2615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.